Healthcare Sector Stocks
The Healthcare sector has a total of 1056 stocks, with a combined market cap of $8.46 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 42.00.
Market Cap
8.46T
Revenue
4.59T
Profits
201.51B
PE Ratio
42.00
Profit Margin
4.39%
Dividend Yield
0.43%
1057 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.00T | -0.61% | 2,257,695 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 566.13B | -0.20% | 7,023,648 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 393.06B | 0.40% | 5,891,034 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 370.21B | -0.82% | 4,747,317 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 284.45B | 0.23% | 10,650,426 | 65.77B |
| 6 | NVS | Novartis AG | 277.43B | -0.42% | 1,584,248 | 56.58B |
| 7 | AZN | AstraZeneca PLC | 276.52B | 0.81% | 1,890,753 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 192.70B | -0.84% | 7,079,010 | 50.57B |
| 9 | AMGN | Amgen Inc. | 187.73B | -0.77% | 3,427,015 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 175.64B | -0.23% | 1,410,896 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 157.96B | 2.36% | 6,805,306 | 29.74B |
| 12 | ABT | Abbott Laboratories | 157.84B | 2.20% | 12,567,675 | 45.13B |
| 13 | PFE | Pfizer Inc. | 148.41B | 0.15% | 32,757,652 | 63.32B |
| 14 | ISRG | Intuitive Surgical, Inc. | 147.71B | 0.12% | 1,835,258 | 10.58B |
| 15 | CVS | CVS Health Corporation | 128.51B | 0.04% | 4,974,198 | 405.62B |
| 16 | DHR | Danaher Corporation | 128.35B | 0.14% | 2,763,409 | 24.78B |
| 17 | SYK | Stryker Corporation | 119.06B | 0.86% | 1,750,429 | 25.27B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 115.02B | 0.60% | 1,204,344 | 12.22B |
| 19 | BMY | Bristol-Myers Squibb Company | 114.19B | -0.57% | 11,926,548 | 48.48B |
| 20 | SNY | Sanofi | 105.19B | 0.57% | 1,574,420 | 54.60B |
| 21 | GSK | GSK plc | 105.04B | -0.02% | 3,853,936 | 43.29B |
| 22 | MDT | Medtronic plc | 104.41B | 1.17% | 8,093,231 | 36.36B |
| 23 | MCK | McKesson Corporation | 91.96B | 0.72% | 657,537 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 88.05B | 1.78% | 1,134,682 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 86.39B | -1.02% | 1,193,843 | 200.42B |
| 26 | CI | The Cigna Group | 77.21B | -0.66% | 1,069,546 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 69.74B | 0.34% | 11,069,991 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 62.54B | -0.04% | 1,005,599 | 14.92B |
| 29 | COR | Cencora, Inc. | 54.76B | 0.01% | 1,008,914 | 328.68B |
| 30 | ARGX | argenx SE | 54.54B | -0.65% | 244,760 | 4.74B |
| 31 | CAH | Cardinal Health, Inc. | 53.33B | 0.58% | 2,832,278 | 250.74B |
| 32 | EW | Edwards Lifesciences Corporation | 51.00B | 2.67% | 4,663,070 | 6.30B |
| 33 | TAK | Takeda Pharmaceutical Company Limited | 49.52B | -0.70% | 1,703,692 | 28.34B |
| 34 | MDLN | Medline Inc. | 48.73B | -0.63% | 8,481,386 | 29.14B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 45.20B | 0.53% | 479,682 | 4.45B |
| 36 | HUM | Humana Inc. | 44.36B | -2.83% | 1,595,654 | 137.20B |
| 37 | BDX | Becton, Dickinson and Company | 40.00B | -0.25% | 1,509,635 | 22.23B |
| 38 | HLN | Haleon plc | 39.63B | 0.22% | 10,655,455 | 14.85B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 38.32B | -2.32% | 4,029,590 | 17.35B |
| 40 | ALNY | Alnylam Pharmaceuticals, Inc. | 37.64B | -2.05% | 1,213,087 | 4.29B |
| 41 | A | Agilent Technologies, Inc. | 36.25B | -1.72% | 2,354,464 | 7.23B |
| 42 | WAT | Waters Corporation | 35.40B | 0.78% | 1,053,926 | 3.77B |
| 43 | RVMD | Revolution Medicines, Inc. | 33.29B | -2.17% | 1,718,519 | - |
| 44 | ZTS | Zoetis Inc. | 33.26B | -0.78% | 5,557,508 | 9.53B |
| 45 | ALC | Alcon Inc. | 32.50B | -0.68% | 1,792,096 | 10.63B |
| 46 | NTRA | Natera, Inc. | 31.52B | 1.45% | 1,378,667 | 2.50B |
| 47 | RPRX | Royalty Pharma plc | 31.22B | -0.11% | 2,831,596 | 2.44B |
| 48 | CNC | Centene Corporation | 30.31B | -3.17% | 5,142,216 | 178.33B |
| 49 | IQV | IQVIA Holdings Inc. | 29.90B | 0.44% | 977,650 | 16.63B |
| 50 | ONC | BeOne Medicines AG | 29.34B | -1.58% | 297,407 | 5.70B |
| 51 | BIIB | Biogen Inc. | 28.88B | -1.53% | 1,105,698 | 9.94B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 28.76B | -2.36% | 4,615,958 | 20.98B |
| 53 | DXCM | DexCom, Inc. | 28.23B | -1.43% | 3,258,003 | 4.82B |
| 54 | RMD | ResMed Inc. | 28.01B | 0.62% | 1,084,994 | 5.54B |
| 55 | VEEV | Veeva Systems Inc. | 26.54B | 0.75% | 1,983,179 | 3.32B |
| 56 | PHG | Koninklijke Philips N.V. | 25.49B | 0.41% | 582,669 | 20.34B |
| 57 | ILMN | Illumina, Inc. | 24.86B | -1.56% | 1,260,586 | 4.39B |
| 58 | WST | West Pharmaceutical Services, Inc. | 23.28B | -0.56% | 770,706 | 3.22B |
| 59 | UTHR | United Therapeutics Corporation | 23.27B | -0.24% | 595,791 | 3.17B |
| 60 | MTD | Mettler-Toledo International Inc. | 23.27B | -0.25% | 92,634 | 4.09B |
| 61 | BNTX | BioNTech SE | 22.63B | -1.43% | 818,925 | 3.23B |
| 62 | DGX | Quest Diagnostics Incorporated | 22.25B | -0.56% | 1,010,403 | 11.28B |
| 63 | MRNA | Moderna, Inc. | 21.98B | 6.27% | 11,351,185 | 2.23B |
| 64 | ROIV | Roivant Sciences Ltd. | 21.87B | 1.27% | 3,886,121 | 8.26M |
| 65 | LH | Labcorp Holdings Inc. | 21.71B | -0.10% | 503,907 | 14.14B |
| 66 | INSM | Insmed Incorporated | 20.70B | -1.99% | 3,421,564 | 819.56M |
| 67 | STE | STERIS plc | 20.13B | 0.28% | 848,256 | 5.94B |
| 68 | INCY | Incyte Corporation | 19.93B | -2.19% | 1,556,030 | 5.36B |
| 69 | VTRS | Viatris Inc. | 18.68B | -1.72% | 6,310,141 | 14.56B |
| 70 | ZBH | Zimmer Biomet Holdings, Inc. | 17.28B | 1.21% | 2,648,290 | 8.41B |
| 71 | GH | Guardant Health, Inc. | 16.89B | -1.91% | 2,582,858 | 1.08B |
| 72 | THC | Tenet Healthcare Corporation | 15.81B | 2.48% | 1,393,699 | 21.46B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 15.73B | -1.94% | 923,174 | 3.10B |
| 74 | GMAB | Genmab A/S | 14.83B | 0.65% | 2,189,812 | 3.90B |
| 75 | ASND | Ascendis Pharma A/S | 14.36B | 3.54% | 812,250 | 998.25M |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 14.24B | -1.60% | 770,209 | 4.44B |
| 77 | DVA | DaVita Inc. | 13.42B | -0.37% | 761,219 | 13.84B |
| 78 | BTSG | BrightSpring Health Services, Inc. | 13.36B | 0.09% | 1,594,535 | 13.65B |
| 79 | SOLV | Solventum Corporation | 13.26B | -0.44% | 1,327,160 | 8.26B |
| 80 | MEDP | Medpace Holdings, Inc. | 13.18B | -1.26% | 170,755 | 2.68B |
| 81 | COO | The Cooper Companies, Inc. | 13.14B | -0.61% | 2,508,614 | 4.23B |
| 82 | EXEL | Exelixis, Inc. | 13.10B | -1.70% | 1,676,191 | 2.38B |
| 83 | BBIO | BridgeBio Pharma, Inc. | 13.05B | -2.00% | 2,216,626 | 579.96M |
| 84 | AXSM | Axsome Therapeutics, Inc. | 12.96B | -0.59% | 606,924 | 708.24M |
| 85 | SNN | Smith & Nephew plc | 12.88B | 0.13% | 849,080 | 6.16B |
| 86 | ALGN | Align Technology, Inc. | 12.86B | 0.71% | 635,195 | 4.10B |
| 87 | FMS | Fresenius Medical Care AG | 12.68B | 1.28% | 452,683 | 22.32B |
| 88 | PEN | Penumbra, Inc. | 12.53B | 0.08% | 274,260 | 1.45B |
| 89 | ELAN | Elanco Animal Health Incorporated | 12.10B | -0.25% | 3,664,042 | 4.89B |
| 90 | IONS | Ionis Pharmaceuticals, Inc. | 12.08B | -1.18% | 1,800,859 | 1.06B |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.56B | 0.29% | 231,956 | 1.13B |
| 92 | RVTY | Revvity, Inc. | 11.29B | 0.67% | 1,294,175 | 2.90B |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 11.25B | -0.23% | 1,301,884 | 3.58B |
| 94 | ICLR | ICON Public Limited Company | 10.97B | -2.83% | 568,494 | 8.25B |
| 95 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.78B | -0.78% | 917,017 | 622.01M |
| 96 | SMMT | Summit Therapeutics Inc. | 10.77B | -1.77% | 5,502,599 | - |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.65B | -0.95% | 1,447,237 | 3.24B |
| 98 | BAX | Baxter International Inc. | 10.57B | -1.68% | 6,774,590 | 11.32B |
| 99 | GMED | Globus Medical, Inc. | 10.52B | 0.26% | 1,338,350 | 3.10B |
| 100 | MOH | Molina Healthcare, Inc. | 10.43B | -0.82% | 698,327 | 43.10B |
| 101 | PODD | Insulet Corporation | 10.23B | -0.30% | 942,132 | 2.90B |
| 102 | CYTK | Cytokinetics, Incorporated | 10.21B | 5.37% | 3,972,217 | 105.82M |
| 103 | EHC | Encompass Health Corporation | 9.90B | 0.48% | 1,096,621 | 6.07B |
| 104 | NUVL | Nuvalent, Inc. | 9.75B | 0.03% | 2,156,889 | - |
| 105 | KRYS | Krystal Biotech, Inc. | 9.53B | -0.42% | 233,538 | 417.30M |
| 106 | HSIC | Henry Schein, Inc. | 9.25B | 0.15% | 791,910 | 13.38B |
| 107 | ENSG | The Ensign Group, Inc. | 9.10B | 4.13% | 772,809 | 5.27B |
| 108 | TEM | Tempus AI, Inc. | 9.08B | -3.36% | 6,229,409 | 1.36B |
| 109 | CORT | Corcept Therapeutics Incorporated | 8.99B | 0.71% | 767,857 | 769.10M |
| 110 | CRL | Charles River Laboratories International, Inc. | 8.90B | -1.95% | 352,337 | 4.03B |
| 111 | UHS | Universal Health Services, Inc. | 8.89B | 0.64% | 659,320 | 17.76B |
| 112 | TECH | Bio-Techne Corporation | 8.77B | -0.25% | 1,529,548 | 1.21B |
| 113 | OSCR | Oscar Health, Inc. | 8.60B | -1.99% | 4,305,782 | 13.30B |
| 114 | BRKR | Bruker Corporation | 8.49B | -1.47% | 1,763,876 | 3.46B |
| 115 | RGC | Regencell Bioscience Holdings Limited | 8.29B | -2.11% | 157,342 | - |
| 116 | HALO | Halozyme Therapeutics, Inc. | 8.26B | -2.30% | 1,950,031 | 1.51B |
| 117 | ABVX | ABIVAX Société Anonyme | 7.87B | -0.77% | 1,943,396 | 5.67M |
| 118 | BIO | Bio-Rad Laboratories, Inc. | 7.76B | 0.23% | 264,332 | 2.59B |
| 119 | ATR | AptarGroup, Inc. | 7.70B | 2.18% | 474,714 | 3.87B |
| 120 | QGEN | Qiagen N.V. | 7.70B | 0.57% | 2,059,705 | 2.10B |
| 121 | GKOS | Glaukos Corporation | 7.49B | -2.01% | 724,432 | 551.35M |
| 122 | RGEN | Repligen Corporation | 7.43B | 0.63% | 612,284 | 763.34M |
| 123 | ALKS | Alkermes plc | 7.35B | -0.61% | 1,420,462 | 1.56B |
| 124 | HIMS | Hims & Hers Health, Inc. | 7.28B | 4.31% | 20,001,834 | 2.37B |
| 125 | SYRE | Spyre Therapeutics, Inc. | 7.24B | -0.20% | 1,337,022 | - |
| 126 | KYMR | Kymera Therapeutics, Inc. | 7.19B | 2.16% | 436,827 | 51.48M |
| 127 | PRAX | Praxis Precision Medicines, Inc. | 7.17B | -2.76% | 497,845 | 7.46M |
| 128 | TGTX | TG Therapeutics, Inc. | 7.16B | 0.48% | 1,476,386 | 700.35M |
| 129 | HQY | HealthEquity, Inc. | 7.16B | -1.51% | 1,632,658 | 1.34B |
| 130 | PCVX | Vaxcyte, Inc. | 7.12B | -0.50% | 999,026 | - |
| 131 | PTGX | Protagonist Therapeutics, Inc. | 7.12B | -1.62% | 338,750 | 74.06M |
| 132 | IBRX | ImmunityBio, Inc. | 7.04B | -5.75% | 12,670,622 | 140.98M |
| 133 | IMVT | Immunovant, Inc. | 6.89B | 0.36% | 1,119,380 | - |
| 134 | LNTH | Lantheus Holdings, Inc. | 6.84B | 0.34% | 1,423,624 | 1.55B |
| 135 | AVTR | Avantor, Inc. | 6.53B | -1.44% | 5,365,772 | 6.55B |
| 136 | GRFS | Grifols, S.A. | 6.45B | -0.39% | 269,108 | 8.58B |
| 137 | APGE | Apogee Therapeutics, Inc. | 6.39B | -1.10% | 1,045,073 | - |
| 138 | LEGN | Legend Biotech Corporation | 6.20B | -5.92% | 2,005,153 | 1.14B |
| 139 | MIRM | Mirum Pharmaceuticals, Inc. | 6.19B | 0.54% | 868,705 | 569.61M |
| 140 | CNTA | Centessa Pharmaceuticals plc | 6.15B | -0.03% | 2,018,099 | 15.00M |
| 141 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.15B | 0.02% | 609,444 | 217.17M |
| 142 | PTCT | PTC Therapeutics, Inc. | 6.08B | -4.56% | 6,310,593 | 827.11M |
| 143 | LQDA | Liquidia Corporation | 6.05B | -5.28% | 2,323,237 | 288.07M |
| 144 | CHE | Chemed Corporation | 5.74B | 2.45% | 216,915 | 2.54B |
| 145 | PACS | PACS Group, Inc. | 5.68B | -0.99% | 539,218 | 5.43B |
| 146 | TFX | Teleflex Incorporated | 5.66B | -1.71% | 426,441 | 2.13B |
| 147 | COGT | Cogent Biosciences, Inc. | 5.65B | -0.30% | 1,603,036 | - |
| 148 | SRRK | Scholar Rock Holding Corporation | 5.46B | -0.78% | 957,600 | - |
| 149 | BLTE | Belite Bio, Inc | 5.44B | -4.19% | 289,970 | - |
| 150 | BLCO | Bausch + Lomb Corporation | 5.34B | -0.07% | 386,921 | 5.21B |
| 151 | CGON | CG Oncology, Inc. | 5.32B | 1.23% | 530,604 | 5.07M |
| 152 | TWST | Twist Bioscience Corporation | 5.29B | 5.15% | 2,481,187 | 409.48M |
| 153 | HNGE | Hinge Health, Inc. | 5.25B | -0.79% | 2,313,509 | 646.34M |
| 154 | AMRX | Amneal Pharmaceuticals, Inc. | 5.18B | 0.06% | 1,739,762 | 3.05B |
| 155 | LGND | Ligand Pharmaceuticals Incorporated | 5.12B | 0.90% | 220,574 | 274.48M |
| 156 | CAI | Caris Life Sciences, Inc. | 5.08B | -1.10% | 1,802,864 | 907.29M |
| 157 | XENE | Xenon Pharmaceuticals Inc. | 5.03B | -0.78% | 709,234 | 7.50M |
| 158 | CRSP | CRISPR Therapeutics AG | 5.02B | -1.13% | 1,101,748 | 4.10M |
| 159 | TVTX | Travere Therapeutics, Inc. | 5.00B | -0.78% | 2,080,407 | 536.20M |
| 160 | TNGX | Tango Therapeutics, Inc. | 4.65B | -2.25% | 3,094,212 | 56.99M |
| 161 | BLLN | BillionToOne, Inc. | 4.63B | -3.13% | 724,071 | 354.54M |
| 162 | SHC | Sotera Health Company | 4.57B | -1.17% | 1,810,058 | 1.19B |
| 163 | STVN | Stevanato Group S.p.A. | 4.51B | -0.72% | 505,870 | 1.39B |
| 164 | RDNT | RadNet, Inc. | 4.46B | -0.67% | 832,554 | 2.14B |
| 165 | LIVN | LivaNova PLC | 4.37B | -0.28% | 911,898 | 1.43B |
| 166 | DNTH | Dianthus Therapeutics, Inc. | 4.31B | -4.40% | 698,247 | 1.34M |
| 167 | ALHC | Alignment Healthcare, Inc. | 4.26B | 4.15% | 6,883,614 | 4.26B |
| 168 | CELC | Celcuity Inc. | 4.26B | -1.04% | 866,261 | - |
| 169 | ERAS | Erasca, Inc. | 4.16B | -7.28% | 3,917,103 | - |
| 170 | MMED | MiniMed Group, Inc. | 4.13B | -2.00% | 438,954 | 3.10B |
| 171 | ORKA | Oruka Therapeutics, Inc. | 4.08B | -1.70% | 815,197 | - |
| 172 | VCYT | Veracyte, Inc. | 4.06B | 3.60% | 1,573,309 | 541.74M |
| 173 | MMSI | Merit Medical Systems, Inc. | 4.04B | 1.11% | 865,451 | 1.54B |
| 174 | TXG | 10x Genomics, Inc. | 4.03B | -1.46% | 2,961,620 | 638.78M |
| 175 | NVST | Envista Holdings Corporation | 4.03B | 0.28% | 1,634,637 | 2.81B |
| 176 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.02B | -0.08% | 372,071 | 754.05M |
| 177 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | -0.06% | 1,770,975 | 596.96M |
| 178 | DOCS | Doximity, Inc. | 3.82B | 1.02% | 1,749,304 | 644.86M |
| 179 | MANE | Veradermics, Incorporated | 3.80B | -5.53% | 496,901 | - |
| 180 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.69B | -0.34% | 482,252 | 18.07M |
| 181 | EWTX | Edgewise Therapeutics, Inc. | 3.65B | -3.58% | 6,413,922 | - |
| 182 | CON | Concentra Group Holdings Parent, Inc. | 3.64B | 1.10% | 910,909 | 2.23B |
| 183 | ACAD | ACADIA Pharmaceuticals Inc. | 3.59B | -1.53% | 1,241,335 | 1.10B |
| 184 | IRTC | iRhythm Holdings, Inc. | 3.58B | -4.32% | 447,176 | 787.85M |
| 185 | ICUI | ICU Medical, Inc. | 3.56B | -0.95% | 235,401 | 2.16B |
| 186 | NAMS | NewAmsterdam Pharma Company N.V. | 3.54B | -1.11% | 1,156,636 | 22.57M |
| 187 | WAY | Waystar Holding Corp. | 3.53B | -0.92% | 1,623,467 | 1.16B |
| 188 | OGN | Organon & Co. | 3.52B | -0.15% | 2,543,395 | 6.16B |
| 189 | DNLI | Denali Therapeutics Inc. | 3.48B | -1.31% | 1,441,764 | - |
| 190 | VKTX | Viking Therapeutics, Inc. | 3.44B | 0.07% | 1,165,497 | - |
| 191 | OPCH | Option Care Health, Inc. | 3.39B | 1.84% | 1,949,843 | 5.67B |
| 192 | PBLS | Parabilis Medicines, Inc. | 3.39B | 6.32% | 3,377,495 | - |
| 193 | HAE | Haemonetics Corporation | 3.38B | -3.22% | 1,321,938 | 1.33B |
| 194 | LFST | LifeStance Health Group, Inc. | 3.34B | 0.35% | 2,241,224 | 1.49B |
| 195 | TLX | Telix Pharmaceuticals Limited | 3.32B | 0.52% | 552,986 | 803.79M |
| 196 | BKD | Brookdale Senior Living Inc. | 3.28B | 1.03% | 4,119,451 | 3.00B |
| 197 | RLAY | Relay Therapeutics, Inc. | 3.28B | 0.60% | 2,338,360 | 10.68M |
| 198 | ARQT | Arcutis Biotherapeutics, Inc. | 3.21B | 0.35% | 1,519,624 | 415.62M |
| 199 | ITGR | Integer Holdings Corporation | 3.10B | 0.50% | 224,648 | 1.86B |
| 200 | BEAM | Beam Therapeutics Inc. | 3.08B | -0.42% | 1,204,290 | 164.01M |
| 201 | WRBY | Warby Parker Inc. | 3.08B | -4.74% | 3,801,420 | 890.57M |
| 202 | GPCR | Structure Therapeutics Inc. | 3.05B | -0.37% | 659,482 | - |
| 203 | NHC | National HealthCare Corporation | 3.00B | -1.85% | 142,587 | 1.53B |
| 204 | DYN | Dyne Therapeutics, Inc. | 2.99B | -3.52% | 1,137,931 | - |
| 205 | PRVA | Privia Health Group, Inc. | 2.97B | 2.22% | 922,828 | 2.25B |
| 206 | RCUS | Arcus Biosciences, Inc. | 2.96B | -2.61% | 694,952 | 236.00M |
| 207 | ALMS | Alumis Inc. | 2.85B | -2.96% | 888,752 | 8.40M |
| 208 | HTFL | HeartFlow, Inc. | 2.76B | -2.35% | 1,789,611 | 191.42M |
| 209 | ADPT | Adaptive Biotechnologies Corporation | 2.76B | -1.37% | 6,863,304 | 295.41M |
| 210 | GRDN | Guardian Pharmacy Services, Inc. | 2.69B | -1.07% | 377,243 | 1.46B |
| 211 | IDYA | IDEAYA Biosciences, Inc. | 2.69B | 1.12% | 1,168,282 | 225.27M |
| 212 | IRON | Disc Medicine, Inc. | 2.67B | -0.37% | 339,429 | - |
| 213 | DFTX | Definium Therapeutics, Inc. | 2.64B | 1.64% | 1,200,335 | - |
| 214 | TMDX | TransMedics Group, Inc. | 2.62B | 0.45% | 656,562 | 635.89M |
| 215 | TARS | Tarsus Pharmaceuticals, Inc. | 2.61B | -1.82% | 718,769 | 535.08M |
| 216 | CLOV | Clover Health Investments, Corp. | 2.60B | 2.70% | 7,485,317 | 2.21B |
| 217 | ELVN | Enliven Therapeutics, Inc. | 2.59B | 0.45% | 3,453,777 | - |
| 218 | CLDX | Celldex Therapeutics, Inc. | 2.54B | 0.62% | 997,921 | 865.00K |
| 219 | SUPN | Supernus Pharmaceuticals, Inc. | 2.53B | -0.66% | 720,112 | 776.83M |
| 220 | GRAL | GRAIL, Inc. | 2.50B | -2.52% | 414,606 | 156.12M |
| 221 | RARE | Ultragenyx Pharmaceutical Inc. | 2.44B | -2.09% | 2,747,338 | 670.00M |
| 222 | ESTA | Establishment Labs Holdings Inc. | 2.43B | -1.95% | 641,666 | 229.58M |
| 223 | VERA | Vera Therapeutics, Inc. | 2.42B | -1.55% | 1,533,273 | - |
| 224 | KLRA | Kailera Therapeutics, Inc. | 2.40B | -5.69% | 535,119 | - |
| 225 | AXGN | Axogen, Inc. | 2.31B | -0.78% | 1,974,966 | 238.11M |
| 226 | ACHC | Acadia Healthcare Company, Inc. | 2.30B | - | 2,384,184 | 3.37B |
| 227 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.27B | -1.60% | 3,574,223 | 885.72M |
| 228 | PBH | Prestige Consumer Healthcare Inc. | 2.25B | 1.78% | 642,072 | 1.09B |
| 229 | PHVS | Pharvaris N.V. | 2.19B | -0.25% | 149,284 | - |
| 230 | TRVI | Trevi Therapeutics, Inc. | 2.19B | 5.05% | 3,429,934 | - |
| 231 | LMAT | LeMaitre Vascular, Inc. | 2.13B | 1.36% | 192,973 | 256.28M |
| 232 | XRAY | DENTSPLY SIRONA Inc. | 2.09B | 3.06% | 4,972,359 | 3.68B |
| 233 | AUPH | Aurinia Pharmaceuticals Inc. | 2.09B | 1.37% | 1,372,099 | 298.30M |
| 234 | PGNY | Progyny, Inc. | 2.08B | -1.15% | 1,756,553 | 1.29B |
| 235 | SEM | Select Medical Holdings Corporation | 2.06B | -0.24% | 951,997 | 5.52B |
| 236 | KOD | Kodiak Sciences Inc. | 2.06B | -3.29% | 412,605 | - |
| 237 | NKTR | Nektar Therapeutics | 2.04B | -1.43% | 719,476 | 55.63M |
| 238 | NTLA | Intellia Therapeutics, Inc. | 2.03B | -2.48% | 7,765,623 | 66.09M |
| 239 | IMNM | Immunome, Inc. | 2.03B | -0.89% | 877,442 | 4.02M |
| 240 | NEOG | Neogen Corporation | 2.03B | 0.11% | 1,723,169 | 870.56M |
| 241 | NVCR | NovoCure Limited | 2.03B | -0.63% | 895,811 | 674.41M |
| 242 | ZLAB | Zai Lab Limited | 1.99B | - | 354,952 | 453.28M |
| 243 | ADMA | ADMA Biologics, Inc. | 1.99B | 0.94% | 3,401,733 | 509.86M |
| 244 | MLYS | Mineralys Therapeutics, Inc. | 1.98B | 0.29% | 1,434,618 | - |
| 245 | VCEL | Vericel Corporation | 1.96B | 0.47% | 643,251 | 292.09M |
| 246 | SGRY | Surgery Partners, Inc. | 1.96B | -0.03% | 574,296 | 3.34B |
| 247 | HRMY | Harmony Biosciences Holdings, Inc. | 1.96B | -1.02% | 476,394 | 899.11M |
| 248 | OCUL | Ocular Therapeutix, Inc. | 1.96B | -0.56% | 2,329,524 | 52.04M |
| 249 | MD | Pediatrix Medical Group, Inc. | 1.94B | -0.90% | 609,320 | 1.93B |
| 250 | MBX | MBX Biosciences, Inc. | 1.91B | 2.85% | 1,144,562 | - |
| 251 | ASTH | Astrana Health, Inc. | 1.90B | -0.03% | 448,348 | 3.53B |
| 252 | AGIO | Agios Pharmaceuticals, Inc. | 1.89B | 0.08% | 788,059 | 66.05M |
| 253 | AGL | agilon health, inc. | 1.89B | -0.94% | 239,961 | 5.82B |
| 254 | BHC | Bausch Health Companies Inc. | 1.85B | -0.60% | 2,128,797 | 10.53B |
| 255 | HCM | HUTCHMED (China) Limited | 1.85B | -3.14% | 37,184 | 548.51M |
| 256 | LKFT | Lakefront Biotherapeutics NV | 1.84B | -1.67% | 199,968 | 1.20B |
| 257 | RAPP | Rapport Therapeutics, Inc. | 1.84B | 0.60% | 156,671 | 20.00M |
| 258 | BHVN | Biohaven Ltd. | 1.82B | -0.41% | 2,374,783 | - |
| 259 | STOK | Stoke Therapeutics, Inc. | 1.82B | -2.83% | 406,830 | 32.08M |
| 260 | OMCL | Omnicell, Inc. | 1.81B | -0.23% | 614,432 | 1.23B |
| 261 | WGS | GeneDx Holdings Corp. | 1.80B | -1.17% | 712,664 | 442.68M |
| 262 | UFPT | UFP Technologies, Inc. | 1.79B | -0.84% | 222,650 | 608.85M |
| 263 | MESO | Mesoblast Limited | 1.79B | -0.07% | 124,879 | 65.38M |
| 264 | NBTX | Nanobiotix S.A. | 1.78B | -4.77% | 64,357 | 38.27M |
| 265 | NUVB | Nuvation Bio Inc. | 1.78B | -0.39% | 3,622,481 | 143.05M |
| 266 | NRIX | Nurix Therapeutics, Inc. | 1.77B | 0.18% | 1,462,976 | 71.78M |
| 267 | VRDN | Viridian Therapeutics, Inc. | 1.76B | -1.96% | 1,255,910 | 70.92M |
| 268 | ANIP | ANI Pharmaceuticals, Inc. | 1.76B | 0.86% | 180,551 | 923.71M |
| 269 | ADUS | Addus HomeCare Corporation | 1.73B | -0.20% | 213,851 | 1.45B |
| 270 | PLSE | Pulse Biosciences, Inc. | 1.73B | -3.57% | 269,593 | 751.00K |
| 271 | GENB | Generate Biomedicines, Inc. | 1.71B | -1.55% | 410,830 | 30.30M |
| 272 | IOVA | Iovance Biotherapeutics, Inc. | 1.71B | -5.21% | 8,035,234 | 285.61M |
| 273 | QURE | uniQure N.V. | 1.70B | -3.16% | 610,778 | 18.09M |
| 274 | PGEN | Precigen, Inc. | 1.69B | -1.04% | 3,174,713 | 31.60M |
| 275 | RXRX | Recursion Pharmaceuticals, Inc. | 1.69B | -3.34% | 14,396,869 | 66.41M |
| 276 | TSHA | Taysha Gene Therapies, Inc. | 1.68B | -2.01% | 1,645,936 | 7.47M |
| 277 | ANAB | AnaptysBio, Inc. | 1.68B | -3.19% | 402,577 | 232.39M |
| 278 | TYRA | Tyra Biosciences, Inc. | 1.67B | -1.37% | 633,584 | - |
| 279 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.67B | -1.02% | 1,117,584 | -665.00K |
| 280 | INVA | Innoviva, Inc. | 1.67B | 0.85% | 558,550 | 420.69M |
| 281 | SRPT | Sarepta Therapeutics, Inc. | 1.67B | 0.06% | 2,193,328 | 2.18B |
| 282 | ZYME | Zymeworks Inc. | 1.64B | -3.18% | 596,759 | 81.26M |
| 283 | SNDX | Syndax Pharmaceuticals, Inc. | 1.64B | 0.38% | 2,166,877 | 217.17M |
| 284 | AVAH | Aveanna Healthcare Holdings Inc. | 1.64B | 4.01% | 1,560,308 | 2.52B |
| 285 | SNDA | Sonida Senior Living, Inc. | 1.63B | 0.84% | 607,807 | 367.34M |
| 286 | SEPN | Septerna, Inc. | 1.59B | -2.39% | 282,907 | 72.26M |
| 287 | PVLA | Palvella Therapeutics, Inc. | 1.58B | -5.42% | 251,730 | - |
| 288 | SION | Sionna Therapeutics, Inc. | 1.57B | -3.47% | 375,107 | - |
| 289 | URGN | UroGen Pharma Ltd. | 1.56B | 3.52% | 562,611 | 140.49M |
| 290 | ABCL | AbCellera Biologics Inc. | 1.55B | -3.23% | 3,635,814 | 79.21M |
| 291 | AAPG | Ascentage Pharma Group International | 1.55B | -1.90% | 13,974 | 82.08M |
| 292 | CMPS | COMPASS Pathways plc | 1.55B | -2.54% | 2,051,847 | - |
| 293 | HCSG | Healthcare Services Group, Inc. | 1.55B | 1.21% | 343,810 | 1.85B |
| 294 | ATAI | AtaiBeckley Inc. | 1.52B | 7.81% | 9,995,108 | 3.49M |
| 295 | NVAX | Novavax, Inc. | 1.51B | -0.11% | 4,144,318 | 596.34M |
| 296 | FTRE | Fortrea Holdings Inc. | 1.51B | -3.91% | 1,472,681 | 2.71B |
| 297 | CAPR | Capricor Therapeutics, Inc. | 1.51B | -2.36% | 654,843 | 11.13M |
| 298 | GLUE | Monte Rosa Therapeutics, Inc. | 1.50B | -1.88% | 790,647 | 42.95M |
| 299 | BFLY | Butterfly Network, Inc. | 1.48B | 0.36% | 4,066,164 | 102.92M |
| 300 | PRGO | Perrigo Company plc | 1.48B | -0.28% | 1,769,322 | 4.18B |
| 301 | VIR | Vir Biotechnology, Inc. | 1.45B | -0.12% | 771,638 | 65.50M |
| 302 | BCAX | Bicara Therapeutics Inc. | 1.44B | 1.81% | 279,422 | - |
| 303 | STAA | STAAR Surgical Company | 1.44B | 1.94% | 468,354 | 290.38M |
| 304 | SLBT | SL Science Holding Limited | 1.44B | 166.97% | 32,900,276 | - |
| 305 | IMCR | Immunocore Holdings plc | 1.43B | -1.61% | 226,950 | 412.81M |
| 306 | HROW | Harrow, Inc. | 1.43B | -1.36% | 374,828 | 268.68M |
| 307 | ATRC | AtriCure, Inc. | 1.42B | - | 524,942 | 552.16M |
| 308 | AVBP | ArriVent BioPharma, Inc. | 1.41B | 0.10% | 320,766 | - |
| 309 | SLS | SELLAS Life Sciences Group, Inc. | 1.40B | -2.59% | 4,270,301 | - |
| 310 | ARDX | Ardelyx, Inc. | 1.40B | -0.26% | 3,373,287 | 427.68M |
| 311 | MLTX | MoonLake Immunotherapeutics | 1.40B | -1.09% | 810,137 | - |
| 312 | ALMR | Alamar Biosciences, Inc. | 1.39B | -3.04% | 218,468 | 87.16M |
| 313 | IART | Integra LifeSciences Holdings Corporation | 1.38B | 1.43% | 861,973 | 1.64B |
| 314 | GHRS | GH Research PLC | 1.37B | -1.64% | 131,547 | - |
| 315 | TDOC | Teladoc Health, Inc. | 1.37B | 1.47% | 2,842,562 | 2.51B |
| 316 | NEO | NeoGenomics, Inc. | 1.37B | -5.41% | 4,968,091 | 745.97M |
| 317 | INBX | Inhibrx Biosciences, Inc. | 1.37B | -0.47% | 331,242 | 1.30M |
| 318 | AHCO | AdaptHealth Corp. | 1.35B | 1.81% | 1,438,210 | 3.29B |
| 319 | SVRA | Savara Inc. | 1.34B | -0.56% | 997,575 | - |
| 320 | ARDT | Ardent Health, Inc. | 1.33B | -2.53% | 1,282,318 | 6.43B |
| 321 | MAZE | Maze Therapeutics, Inc. | 1.32B | -1.57% | 533,771 | 20.00M |
| 322 | ATEC | Alphatec Holdings, Inc. | 1.30B | 1.87% | 1,612,858 | 787.08M |
| 323 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.29B | 1.01% | 1,227,869 | 204.73M |
| 324 | PAHC | Phibro Animal Health Corporation | 1.29B | -1.27% | 200,498 | 1.50B |
| 325 | BLFS | BioLife Solutions, Inc. | 1.29B | -1.24% | 402,932 | 101.66M |
| 326 | DMRA | Damora Therapeutics, Inc. | 1.27B | 2.99% | 363,635 | - |
| 327 | PRCT | PROCEPT BioRobotics Corporation | 1.26B | -4.82% | 3,466,829 | 322.02M |
| 328 | INNV | InnovAge Holding Corp. | 1.25B | 0.87% | 404,604 | 949.17M |
| 329 | AKTS | Aktis Oncology, Inc. | 1.25B | 9.38% | 547,265 | 8.28M |
| 330 | ENOV | Enovis Corporation | 1.24B | 2.86% | 766,124 | 2.28B |
| 331 | IMTX | Immatics N.V. | 1.24B | -3.71% | 154,658 | 43.00M |
| 332 | AMN | AMN Healthcare Services, Inc. | 1.24B | 3.24% | 722,360 | 3.42B |
| 333 | MPLT | MapLight Therapeutics, Inc. | 1.23B | -2.86% | 202,974 | - |
| 334 | ALVO | Alvotech | 1.21B | -8.73% | 5,493,534 | 562.04M |
| 335 | CDNA | CareDx, Inc. | 1.20B | -3.45% | 824,245 | 412.82M |
| 336 | MNKD | MannKind Corporation | 1.20B | -3.25% | 3,159,896 | 360.78M |
| 337 | INSP | Inspire Medical Systems, Inc. | 1.19B | 0.63% | 515,020 | 915.25M |
| 338 | XERS | Xeris Biopharma Holdings, Inc. | 1.19B | 0.29% | 1,462,056 | 314.85M |
| 339 | PNTG | The Pennant Group, Inc. | 1.18B | 2.54% | 109,893 | 1.02B |
| 340 | AVLN | Avalyn Pharma Inc. | 1.17B | -2.37% | 382,426 | - |
| 341 | IRMD | IRADIMED CORPORATION | 1.17B | 1.12% | 132,798 | 86.28M |
| 342 | AVNS | Avanos Medical, Inc. | 1.17B | - | 705,462 | 715.90M |
| 343 | ZBIO | Zenas BioPharma, Inc. | 1.15B | -2.78% | 392,132 | 10.00M |
| 344 | TNDM | Tandem Diabetes Care, Inc. | 1.14B | -0.42% | 1,734,295 | 1.03B |
| 345 | COLL | Collegium Pharmaceutical, Inc. | 1.12B | 1.35% | 181,438 | 796.33M |
| 346 | COAG | Hemab Therapeutics Holdings, Inc. | 1.12B | 1.30% | 375,446 | - |
| 347 | KMTS | Kestra Medical Technologies, Ltd. | 1.12B | -5.91% | 152,080 | 83.72M |
| 348 | SDGR | Schrödinger, Inc. | 1.12B | 2.26% | 1,188,865 | 254.91M |
| 349 | WVE | Wave Life Sciences Ltd. | 1.10B | -4.33% | 1,962,765 | 71.80M |
| 350 | DBVT | DBV Technologies S.A. | 1.09B | -7.56% | 160,831 | 5.74M |
| 351 | ABSI | Absci Corporation | 1.09B | -3.71% | 3,829,557 | 1.84M |
| 352 | EYPT | EyePoint, Inc. | 1.08B | 6.62% | 1,470,799 | 7.61M |
| 353 | AZTA | Azenta, Inc. | 1.07B | 0.78% | 613,782 | 596.48M |
| 354 | OPK | OPKO Health, Inc. | 1.06B | -0.36% | 1,364,963 | 581.12M |
| 355 | AORT | Artivion, Inc. | 1.04B | 1.80% | 934,844 | 458.69M |
| 356 | CNMD | CONMED Corporation | 1.04B | 1.20% | 382,266 | 1.37B |
| 357 | AHG | Akso Health Group | 1.04B | 4.31% | 42,786 | 14.84M |
| 358 | OMDA | Omada Health, Inc. | 1.02B | -1.27% | 553,102 | 283.30M |
| 359 | PSNL | Personalis, Inc. | 1.01B | -1.02% | 2,402,770 | 64.52M |
| 360 | USPH | U.S. Physical Therapy, Inc. | 1.01B | 1.33% | 112,202 | 787.69M |
| 361 | EVO | Evotec SE | 1.01B | -3.91% | 35,516 | 859.03M |
| 362 | NUTX | Nutex Health Inc. | 993.39M | -1.85% | 69,449 | 879.95M |
| 363 | CRVS | Corvus Pharmaceuticals, Inc. | 987.64M | -1.30% | 1,179,115 | - |
| 364 | CRON | Cronos Group Inc. | 986.39M | -1.14% | 909,446 | 159.54M |
| 365 | SPRY | ARS Pharmaceuticals, Inc. | 964.73M | -0.97% | 874,031 | 98.99M |
| 366 | QDEL | QuidelOrtho Corporation | 963.54M | -3.02% | 911,071 | 2.66B |
| 367 | SPTX | Seaport Therapeutics, Inc. | 952.91M | 3.04% | 199,065 | - |
| 368 | CERT | Certara, Inc. | 941.17M | 16.12% | 7,110,304 | 419.75M |
| 369 | AVR | Anteris Technologies Global Corp. | 930.81M | -1.91% | 990,308 | 1.85M |
| 370 | GDRX | GoodRx Holdings, Inc. | 924.58M | - | 1,387,341 | 787.89M |
| 371 | JBIO | Jade Biosciences, Inc. | 921.86M | -3.54% | 1,324,268 | - |
| 372 | BIOA | BioAge Labs, Inc. | 909.95M | 3.18% | 666,217 | 10.32M |
| 373 | XNCR | Xencor, Inc. | 904.53M | -0.08% | 415,879 | 97.36M |
| 374 | MGTX | MeiraGTx Holdings plc | 899.24M | -0.41% | 499,605 | 79.76M |
| 375 | PCRX | Pacira BioSciences, Inc. | 897.53M | 0.31% | 542,732 | 734.86M |
| 376 | PHAR | Pharming Group N.V. | 896.95M | -1.52% | 1,837 | 369.49M |
| 377 | ETON | Eton Pharmaceuticals, Inc. | 886.14M | 0.62% | 137,013 | 86.93M |
| 378 | AMPH | Amphastar Pharmaceuticals, Inc. | 879.65M | 1.22% | 724,186 | 720.53M |
| 379 | TALK | Talkspace, Inc. | 871.07M | - | 2,074,460 | 238.37M |
| 380 | LMRI | Lumexa Imaging Holdings, Inc. | 867.61M | -3.83% | 596,310 | 1.03B |
| 381 | ABUS | Arbutus Biopharma Corporation | 867.19M | 1.62% | 813,488 | 191.45M |
| 382 | LXRX | Lexicon Pharmaceuticals, Inc. | 866.18M | -0.51% | 1,853,925 | 69.64M |
| 383 | TBPH | Theravance Biopharma, Inc. | 860.94M | 2.33% | 267,974 | 109.78M |
| 384 | ORIC | ORIC Pharmaceuticals, Inc. | 858.16M | -1.31% | 1,150,985 | - |
| 385 | INMD | InMode Ltd. | 854.71M | -0.59% | 644,568 | 374.64M |
| 386 | SANA | Sana Biotechnology, Inc. | 848.72M | -0.70% | 2,006,277 | - |
| 387 | ODTX | Odyssey Therapeutics, Inc. | 848.19M | 1.87% | 317,114 | 2.98M |
| 388 | DRTS | Alpha Tau Medical Ltd. | 845.85M | -3.00% | 369,049 | - |
| 389 | JANX | Janux Therapeutics, Inc. | 835.49M | -0.29% | 616,607 | 13.73M |
| 390 | KURA | Kura Oncology, Inc. | 834.48M | -1.47% | 1,014,368 | 71.64M |
| 391 | CGEM | Cullinan Therapeutics, Inc. | 832.14M | -0.51% | 940,032 | - |
| 392 | PHAT | Phathom Pharmaceuticals, Inc. | 828.46M | -2.61% | 749,513 | 204.89M |
| 393 | ESPR | Esperion Therapeutics, Inc. | 813.48M | 0.32% | 7,840,640 | 418.24M |
| 394 | OLMA | Olema Pharmaceuticals, Inc. | 802.72M | -6.98% | 1,205,362 | - |
| 395 | LBRX | LB Pharmaceuticals Inc | 794.34M | -2.81% | 123,550 | - |
| 396 | VOR | Vor Biopharma Inc. | 764.56M | 0.28% | 749,972 | - |
| 397 | GERN | Geron Corporation | 756.99M | 2.61% | 9,398,022 | 196.12M |
| 398 | IVA | Inventiva S.A. | 755.58M | -4.79% | 474,831 | 7.94M |
| 399 | AVTX | Avalo Therapeutics, Inc. | 753.26M | -1.85% | 1,543,370 | 59.00K |
| 400 | HSTM | HealthStream, Inc. | 753.17M | -0.35% | 79,994 | 311.78M |
| 401 | ZVRA | Zevra Therapeutics, Inc. | 747.81M | 0.80% | 1,150,029 | 122.29M |
| 402 | ANNX | Annexon, Inc. | 740.57M | -2.59% | 2,408,963 | - |
| 403 | ANRO | Alto Neuroscience, Inc. | 736.97M | -0.80% | 199,890 | - |
| 404 | BVS | Bioventus Inc. | 728.42M | 1.40% | 298,325 | 576.30M |
| 405 | REPL | Replimune Group, Inc. | 723.75M | -2.18% | 1,547,519 | - |
| 406 | EVMN | Evommune, Inc. | 722.17M | -3.79% | 209,040 | 10.00M |
| 407 | NNNN | Anbio Biotechnology | 708.40M | -3.99% | 39,504 | 8.65M |
| 408 | SSII | SS Innovations International, Inc. | 706.44M | 0.28% | 25,502 | 48.47M |
| 409 | SLDB | Solid Biosciences Inc. | 694.07M | -4.21% | 926,156 | - |
| 410 | AURA | Aura Biosciences, Inc. | 692.13M | -2.71% | 496,597 | - |
| 411 | OCS | Oculis Holding AG | 688.42M | -1.81% | 604,194 | 1.40M |
| 412 | RLMD | Relmada Therapeutics, Inc. | 687.03M | 2.83% | 1,722,665 | - |
| 413 | OMER | Omeros Corporation | 686.12M | 1.61% | 2,362,833 | 9.89M |
| 414 | SIBN | SI-BONE, Inc. | 684.31M | 2.05% | 281,787 | 206.22M |
| 415 | CBLL | CeriBell, Inc. | 679.93M | -3.60% | 206,136 | 95.07M |
| 416 | CRMD | CorMedix Inc. | 679.39M | 0.81% | 696,904 | 400.05M |
| 417 | DSGN | Design Therapeutics, Inc. | 669.54M | -3.77% | 528,121 | - |
| 418 | TENX | Tenax Therapeutics, Inc. | 667.09M | -1.90% | 789,893 | - |
| 419 | ALLO | Allogene Therapeutics, Inc. | 655.79M | -2.06% | 4,792,109 | 22.00K |
| 420 | GMRS | GMR Solutions Inc. | 648.14M | -0.25% | 577,988 | 5.83B |
| 421 | CTMX | CytomX Therapeutics, Inc. | 637.87M | -3.62% | 6,957,089 | 35.54M |
| 422 | BBNX | Beta Bionics, Inc. | 622.53M | -2.85% | 752,637 | 110.24M |
| 423 | IMMX | Immix Biopharma, Inc. | 622.20M | 3.19% | 2,401,836 | - |
| 424 | CSTL | Castle Biosciences, Inc. | 620.25M | -1.02% | 272,087 | 339.92M |
| 425 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 618.43M | -0.13% | 551,143 | - |
| 426 | CLYM | Climb Bio, Inc. | 614.41M | -6.61% | 732,400 | - |
| 427 | ACRS | Aclaris Therapeutics, Inc. | 606.14M | -0.46% | 1,085,538 | 8.37M |
| 428 | IRWD | Ironwood Pharmaceuticals, Inc. | 602.49M | -0.81% | 1,524,125 | 361.51M |
| 429 | RIGL | Rigel Pharmaceuticals, Inc. | 600.58M | -2.87% | 350,569 | 299.77M |
| 430 | TRAX | First Tracks Biotherapeutics, Inc. | 598.06M | -4.14% | 423,866 | - |
| 431 | CBIO | Crescent Biopharma, Inc. | 596.46M | -1.32% | 112,952 | 11.88M |
| 432 | TCMD | Tactile Systems Technology, Inc. | 596.16M | 0.27% | 85,171 | 343.52M |
| 433 | DRUG | Bright Minds Biosciences Inc. | 592.93M | 1.10% | 206,870 | - |
| 434 | SGP | SpyGlass Pharma, Inc. | 589.64M | -6.86% | 103,659 | - |
| 435 | CADL | Candel Therapeutics, Inc. | 583.96M | -6.89% | 1,911,212 | - |
| 436 | PHR | Phreesia, Inc. | 583.50M | 3.17% | 1,034,745 | 495.59M |
| 437 | TLRY | Tilray Brands, Inc. | 582.10M | -2.59% | 3,504,013 | 858.28M |
| 438 | ACHV | Achieve Life Sciences, Inc. | 569.76M | -0.89% | 1,331,549 | - |
| 439 | BWAY | BrainsWay Ltd. | 567.91M | -1.64% | 70,710 | 56.22M |
| 440 | TECX | Tectonic Therapeutic, Inc. | 565.70M | 2.01% | 65,430 | - |
| 441 | MDXG | MiMedx Group, Inc. | 551.10M | 0.54% | 1,066,396 | 389.42M |
| 442 | DNA | Ginkgo Bioworks Holdings, Inc. | 536.31M | -0.24% | 733,050 | 151.40M |
| 443 | GYRE | Gyre Therapeutics, Inc. | 534.53M | -0.17% | 61,236 | 117.05M |
| 444 | AQST | Aquestive Therapeutics, Inc. | 534.42M | 0.95% | 1,052,854 | 50.27M |
| 445 | EVH | Evolent Health, Inc. | 528.66M | - | 1,427,456 | 1.89B |
| 446 | CTKB | Cytek Biosciences, Inc. | 528.19M | 4.07% | 1,739,307 | 204.17M |
| 447 | XOMA | XOMA Royalty Corporation | 523.96M | -0.41% | 109,978 | 48.56M |
| 448 | CTEV | Claritev Corporation | 522.86M | 0.20% | 72,048 | 978.76M |
| 449 | PRME | Prime Medicine, Inc. | 518.37M | -1.03% | 2,023,793 | 4.03M |
| 450 | NPCE | NeuroPace, Inc. | 512.09M | -2.28% | 87,588 | 99.53M |
| 451 | FLGT | Fulgent Genetics, Inc. | 510.93M | -1.96% | 171,386 | 320.35M |
| 452 | PROK | ProKidney Corp. | 510.48M | 1.20% | 484,363 | 889.00K |
| 453 | TOI | The Oncology Institute, Inc. | 509.91M | -1.54% | 1,244,200 | 545.76M |
| 454 | ALT | Altimmune, Inc. | 509.52M | -0.76% | 2,742,960 | 36.00K |
| 455 | SRTA | Strata Critical Medical, Inc. | 505.32M | -0.85% | 1,532,801 | 228.58M |
| 456 | VALN | Valneva SE | 504.32M | -0.56% | 17,549 | 180.25M |
| 457 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 458 | ANGO | AngioDynamics, Inc. | 499.35M | 1.42% | 176,738 | 313.73M |
| 459 | CERS | Cerus Corporation | 494.91M | -1.98% | 1,822,643 | 216.56M |
| 460 | AGMB | AgomAb Therapeutics NV | 493.46M | 0.20% | 102,684 | - |
| 461 | EIKN | Eikon Therapeutics, Inc. | 491.04M | -2.79% | 159,480 | - |
| 462 | ARVN | Arvinas, Inc. | 478.75M | -0.93% | 519,306 | 89.40M |
| 463 | KYTX | Kyverna Therapeutics, Inc. | 478.49M | -3.01% | 598,347 | - |
| 464 | KIDS | OrthoPediatrics Corp. | 477.48M | 2.42% | 48,813 | 243.30M |
| 465 | RZLT | Rezolute, Inc. | 477.41M | 5.54% | 1,768,640 | - |
| 466 | STRO | Sutro Biopharma, Inc. | 466.79M | -6.72% | 317,772 | 99.61M |
| 467 | NGNE | Neurogene Inc. | 463.79M | -1.71% | 160,179 | 925.00K |
| 468 | CTNM | Contineum Therapeutics, Inc. | 463.22M | -2.59% | 571,804 | - |
| 469 | ASMB | Assembly Biosciences, Inc. | 462.24M | -0.06% | 82,623 | 71.10M |
| 470 | CABA | Cabaletta Bio, Inc. | 456.55M | -6.98% | 5,338,285 | - |
| 471 | FDMT | 4D Molecular Therapeutics, Inc. | 453.24M | -5.97% | 628,044 | 88.24M |
| 472 | VREX | Varex Imaging Corporation | 442.12M | 0.48% | 227,651 | 857.50M |
| 473 | OVID | Ovid Therapeutics Inc. | 440.47M | 4.42% | 2,362,947 | 7.12M |
| 474 | MOBI | Mobia Medical, Inc. | 438.05M | 20.25% | 252,396 | 32.04M |
| 475 | EOLS | Evolus, Inc. | 436.62M | -1.78% | 806,648 | 301.79M |
| 476 | WEAV | Weave Communications, Inc. | 435.22M | 0.55% | 681,036 | 248.72M |
| 477 | PRTA | Prothena Corporation plc | 433.75M | 1.66% | 585,996 | 57.94M |
| 478 | ARTV | Artiva Biotherapeutics, Inc. | 432.92M | -2.94% | 780,610 | 251.00K |
| 479 | CYH | Community Health Systems, Inc. | 425.32M | 2.28% | 1,063,453 | 12.29B |
| 480 | CCCC | C4 Therapeutics, Inc. | 424.58M | 0.52% | 1,539,416 | 34.86M |
| 481 | KMDA | Kamada Ltd. | 423.74M | - | 84,872 | 181.68M |
| 482 | INDP | Indaptus Therapeutics, Inc. | 421.26M | 0.81% | 255,525 | - |
| 483 | FBRX | Forte Biosciences, Inc. | 420.90M | -4.57% | 186,335 | - |
| 484 | PACB | Pacific Biosciences of California, Inc. | 419.31M | 2.27% | 3,682,854 | 160.03M |
| 485 | NRC | NRC Health | 417.83M | 1.26% | 68,642 | 138.64M |
| 486 | MNPR | Monopar Therapeutics Inc. | 417.67M | 1.43% | 59,057 | - |
| 487 | PRLD | Prelude Therapeutics Incorporated | 416.55M | -6.28% | 259,573 | 16.72M |
| 488 | CCRN | Cross Country Healthcare, Inc. | 408.69M | 0.08% | 815,095 | 1.00B |
| 489 | EPRX | Eupraxia Pharmaceuticals Inc. | 407.52M | -3.05% | 590,921 | - |
| 490 | ANL | Adlai Nortye Ltd. | 401.00M | -11.52% | 153,019 | 5.00M |
| 491 | MYGN | Myriad Genetics, Inc. | 400.93M | -1.74% | 723,674 | 829.00M |
| 492 | VTVT | vTv Therapeutics Inc. | 400.58M | -3.76% | 78,497 | 36.84M |
| 493 | CLPT | ClearPoint Neuro, Inc. | 400.06M | -1.33% | 210,051 | 40.61M |
| 494 | EBS | Emergent BioSolutions Inc. | 399.87M | -6.51% | 1,820,342 | 676.80M |
| 495 | OCGN | Ocugen, Inc. | 399.46M | -3.28% | 6,967,059 | 4.47M |
| 496 | DCTH | Delcath Systems, Inc. | 398.38M | -2.12% | 318,032 | 90.44M |
| 497 | AUTL | Autolus Therapeutics plc | 397.88M | -0.33% | 858,720 | 92.62M |
| 498 | VMD | Viemed Healthcare, Inc. | 395.64M | -1.15% | 389,995 | 286.57M |
| 499 | IPSC | Century Therapeutics, Inc. | 393.17M | -5.22% | 707,118 | 109.16M |
| 500 | AUNA | Auna S.A. | 390.05M | 5.61% | 192,413 | 1.30B |